Additionally, in vivo studies in mouse models of AMI found an increase in the expression of CX3CL1 during phase 2 of infarction, which suggested the mobilization of Ly-6Clow monocytes (mouse counterparts of human CD14++CD16+/CD14+CD16++ monocytes) [4, 6]. This evidence concerns the gene CX3CL1 and infarction.